U.S. flag

An official website of the United States government

NM_003242.6(TGFBR2):c.1043G>A (p.Arg348His) AND Familial thoracic aortic aneurysm and aortic dissection

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Mar 28, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000809072.8

Allele description

NM_003242.6(TGFBR2):c.1043G>A (p.Arg348His)

Gene:
TGFBR2:transforming growth factor beta receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p24.1
Genomic location:
Preferred name:
NM_003242.6(TGFBR2):c.1043G>A (p.Arg348His)
HGVS:
  • NC_000003.12:g.30672226G>A
  • NG_007490.1:g.70725G>A
  • NM_001024847.3:c.1118G>A
  • NM_001407126.1:c.1226G>A
  • NM_001407127.1:c.1151G>A
  • NM_001407128.1:c.1070G>A
  • NM_001407129.1:c.1046G>A
  • NM_001407130.1:c.1043G>A
  • NM_001407132.1:c.938G>A
  • NM_001407133.1:c.938G>A
  • NM_001407134.1:c.938G>A
  • NM_001407135.1:c.938G>A
  • NM_001407136.1:c.938G>A
  • NM_001407137.1:c.758G>A
  • NM_001407138.1:c.683G>A
  • NM_003242.6:c.1043G>AMANE SELECT
  • NP_001020018.1:p.Arg373His
  • NP_001020018.1:p.Arg373His
  • NP_001394055.1:p.Arg409His
  • NP_001394056.1:p.Arg384His
  • NP_001394057.1:p.Arg357His
  • NP_001394058.1:p.Arg349His
  • NP_001394059.1:p.Arg348His
  • NP_001394061.1:p.Arg313His
  • NP_001394062.1:p.Arg313His
  • NP_001394063.1:p.Arg313His
  • NP_001394064.1:p.Arg313His
  • NP_001394065.1:p.Arg313His
  • NP_001394066.1:p.Arg253His
  • NP_001394067.1:p.Arg228His
  • NP_003233.4:p.Arg348His
  • LRG_779t1:c.1118G>A
  • LRG_779t2:c.1043G>A
  • LRG_779:g.70725G>A
  • LRG_779p1:p.Arg373His
  • LRG_779p2:p.Arg348His
  • NC_000003.11:g.30713718G>A
  • NM_001024847.2:c.1118G>A
  • NM_003242.5:c.1043G>A
Protein change:
R228H
Links:
dbSNP: rs369450067
NCBI 1000 Genomes Browser:
rs369450067
Molecular consequence:
  • NM_001024847.3:c.1118G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407126.1:c.1226G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407127.1:c.1151G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407128.1:c.1070G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407129.1:c.1046G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407130.1:c.1043G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407132.1:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407133.1:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407134.1:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407135.1:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407136.1:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407137.1:c.758G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407138.1:c.683G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003242.6:c.1043G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial thoracic aortic aneurysm and aortic dissection (TAAD)
Synonyms:
Thoracic aortic aneurysm and aortic dissection; Thoracic aortic aneurysms and dissections
Identifiers:
MONDO: MONDO:0019625; MedGen: C4707243; Orphanet: 91387; OMIM: PS607086

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000949211Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Mar 28, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001354469Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 20, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.

Stheneur C, Collod-BĂ©roud G, Faivre L, Gouya L, Sultan G, Le Parc JM, Moura B, Attias D, Muti C, Sznajder M, Claustres M, Junien C, Baumann C, Cormier-Daire V, Rio M, Lyonnet S, Plauchu H, Lacombe D, Chevallier B, Jondeau G, Boileau C.

Hum Mutat. 2008 Nov;29(11):E284-95. doi: 10.1002/humu.20871.

PubMed [citation]
PMID:
18781618
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV000949211.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TGFBR2 protein function. ClinVar contains an entry for this variant (Variation ID: 432420). This missense change has been observed in individual(s) with clinical features of TGFBR2-related disease (PMID: 18781618). This variant is present in population databases (rs369450067, gnomAD 0.008%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 348 of the TGFBR2 protein (p.Arg348His).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV001354469.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This missense variant replaces arginine with histidine at codon 348 of the TGFBR2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual suspected with Marfan syndrome or related disorders (PMID: 18781618). This variant has been identified in 10/280264 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024